Embryonic and induced pluripotent stem cells: understanding, creating, and exploiting the nano-niche for regenerative medicine

ACS Nano. 2013 Mar 26;7(3):1867-81. doi: 10.1021/nn3037094. Epub 2013 Feb 15.

Abstract

Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) have the capacity to differentiate into any specialized cell type of the human body, and therefore, ESC/iPSC-derived cell types offer great potential for regenerative medicine. However, key to realizing this potential requires a strong understanding of stem cell biology, techniques to maintain stem cells, and strategies to manipulate cells to efficiently direct cell differentiation toward a desired cell type. As nanoscale science and engineering continues to produce novel nanotechnology platforms, which inform, infiltrate, and impinge on many aspects of everyday life, it is no surprise that stem cell research is turning toward developments in nanotechnology to answer research questions and to overcome obstacles in regenerative medicine. Here we discuss recent advances in ESC and iPSC manipulation using nanomaterials and highlight future challenges within this area of research.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell Differentiation
  • Embryonic Stem Cells / cytology*
  • Embryonic Stem Cells / transplantation
  • Humans
  • Induced Pluripotent Stem Cells / cytology*
  • Induced Pluripotent Stem Cells / transplantation
  • Nanomedicine
  • Nanostructures
  • Nanotechnology
  • Regenerative Medicine
  • Stem Cell Niche
  • Stem Cell Transplantation